NCT02892526

Brief Summary

The purpose is to determine intrinsic properties of various immunohistochemical markers (FVIIIra, CD15, CD30, tryptase, TNFα, IL-1β, TGFα et TGFβ1) for diagnosis of vital wound, alone and in association (evaluation of sensibility with surgery wounds and evaluation of specificity with post-mortem wounds). Secondary purposes are to measure the minimum time to obtain a positive labeling in vital wounds, and to evaluate inter-observer reproducibility of vitality diagnosis with different markers. Expression of microRNA miR 9, miR 21 et miR 198 will be also studied.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
57

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Dec 2014

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2014

Completed
1.8 years until next milestone

First Submitted

Initial submission to the registry

September 2, 2016

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 8, 2016

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2016

Completed
Last Updated

September 8, 2016

Status Verified

September 1, 2016

Enrollment Period

2 years

First QC Date

September 2, 2016

Last Update Submit

September 2, 2016

Conditions

Outcome Measures

Primary Outcomes (2)

  • Sensibility of markers for vitality diagnosis

    baseline

  • Specificity of markers for vitality diagnosis

    baseline

Secondary Outcomes (5)

  • Minimum time to obtain a labeling (between incision and devascularization)

    baseline

  • Coefficient of inter-observer correlation of vitality diagnosis (for reproducibility analysis)

    baseline

  • Expression level of miR 9 by qRT-PCR

    baseline

  • Expression level of miR 21 by qRT-PCR

    baseline

  • Expression level of miR 198 by qRT-PCR

    baseline

Study Arms (2)

Vital wounds

from abdominoplasty of alive persons

Other: Abdominoplasty with exeresis of cutaneous tissue

Post-mortem wounds

from autopsy of deceased persons

Other: Collection of cutaneous tissue

Interventions

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients operated in Plastic and Reconstructive Surgery and Maxillofacial Surgery departments at CHRU Nancy for therapeutic abdominoplasty. Deceased patients, whose medico-scientific autopsies are performed for diagnosis in Anatomy and Pathological Cytology or Legal Medicine departments.

You may qualify if:

  • Alive persons:
  • \- Abdominoplasty
  • Deceased persons:
  • \- Medico-scientific autopsy for diagnosis

You may not qualify if:

  • Alive persons:
  • Fragmented sample with non-visible banks
  • Cutaneous pathology
  • Deceased persons:
  • Persons under protection
  • Medico-legal obstacle
  • Cutaneous pathology

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHRU Nancy

Nancy, France

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

Cutaneous tissue

MeSH Terms

Conditions

Wounds and Injuries

Interventions

Abdominoplasty

Intervention Hierarchy (Ancestors)

Cosmetic TechniquesTherapeuticsPlastic Surgery ProceduresSurgical Procedures, Operative

Study Officials

  • Laurent MARTRILLE

    Service de Médecine Légale - CHRU de Nancy

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Laurent MARTRILLE

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 2, 2016

First Posted

September 8, 2016

Study Start

December 1, 2014

Primary Completion

December 1, 2016

Study Completion

December 1, 2016

Last Updated

September 8, 2016

Record last verified: 2016-09

Data Sharing

IPD Sharing
Will not share

Locations